advisory committee

Optimer Pharma Jumps After Stock Grants, Ahead of FDA Advisory Meeting

Each stock option has an exercise price per share equal to $11.83, the fair market value on the grant date, and vests over four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commenceme

advisory committee, board, diarrhea, drug, fda, fidaxomicin, financial, infection, medical, optimer, optr, patient, pharma, shares, stock, treatment

Optimer Pharmaceuticals (OPTR) says that on March 31, its Board approved the grant of inducement stock options to purchase an aggregate of 258,000 shares of common stock to 7 new employees.

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Recent 52-Week Low Surpassed in Shares o...

Unisys (NYSE:UIS) traded at a new 52-week low today of $21.09. Approximately 5.1 milli ...

TransCanada: 52-Week High Recently Eclip...

TransCanada (NYSE:TRP) traded at a new 52-week high today of $51.46. So far today appr ...

Recent 52-Week High Exceeded in Shares o...

Shares of Trinity Industries (NYSE:TRN) traded today at $46.17, breaking its 52-week hi ...

Watch for Continued Gains in Shares of S...

Shares of Sasol (NYSE:SSL) traded today at $60.69, breaking its 52-week high. So far t ...

Shares of China Petroleum & Chemical Ris...

China Petroleum & Chemical (NYSE:SNP) traded today at a new 52-week high of $98.89. Ap ...

Saia Looks to Continue to Trade Above it...

Shares of Saia (NASDAQ:SAIA) traded at a new 52-week high today of $47.94. So far toda ...

Watch for Continued Gains in Shares of R...

Robert Half International (NYSE:RHI) traded today at a new 52-week high of $53.08. So ...

RPC Looks to Continue to Trade Above its...

RPC (NYSE:RES) traded at a new 52-week high today of $24.50. So far today approximatel ...

Most Popular Video News